The dividend signals capital return discipline and stable cash flow, but lacks material upside without confirmation of 2025 net income or revised guidance. Traders should monitor for disclosure of the tax ruling for non-Israeli shareholders and any follow-up financial reporting.
KMDA drugs
KMDA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 11 $8.30entry
- T+1 · 8mo ago +1.64%α +3.12% · $8.43
- T+5 · 8mo ago +0.47%α +2.66% · $8.34
- T+20 · 7mo ago +2.55%α +2.02% · $8.51
- T+60 · 6mo ago −10.95%α −22.47% · $7.39
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Kamada Ltd. declared a cash dividend of $0.25 per share, totaling approximately $14.4 million, payable on April 6, 2026, to shareholders of record as of March 23, 2026. The dividend reflects the company's new annual policy to distribute at least 50% of annual net income, subject to board discretion and legal requirements under Israeli law.
Key Facts
- Kamada declared a cash dividend of $0.25 per share, totaling $14.4 million.
- Dividend payable on April 6, 2026, to shareholders of record on March 23, 2026.
- New dividend policy targets annual payouts of at least 50% of net income, subject to board approval and Israeli legal requirements.
- No financial results for 2025 were disclosed beyond reference to 'strong financial results' in management commentary.
- FIMI Opportunity Funds owns approximately 38% of outstanding shares.
Financial Impact
$14.4 million total payout, $0.25 per share
Risk Factors
- Forward-looking statements about future dividends are contingent on earnings, board discretion, and geopolitical risks in Israel and the Middle East.
- No actual 2025 financials (revenue, net income, EPS) were provided to verify the 50% payout ratio.
- Geopolitical risks in the region could impact operations and investor sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3253633 |
Track record
25 reports on KMDA
8 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +16.13% at T+20 after the Aug 12, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 9, 20267d ago 6-K Bullish 6/10 No price data
- Nov 9, 20267d ago Press Release Bullish 6/10 Entry $7.71 to $8.11 Now $8.11 +5.19% ▲ +5.19% +6.88% vs SPY
- Nov 2, 202614d ago 6-K Neutral 2/10 Entry $7.36 to $7.71 Now $8.11 +10.19% ▲ +4.76% +4.68% vs SPY
- Oct 6, 20265w ago 6-K Neutral 4/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 6, 20265w ago Press Release Bullish 6/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Oct 5, 20266w ago 6-K Neutral 2/10 Entry $8.11 to $7.69 Now $8.11 −0.00% ▼ −5.18% −5.04% vs SPY
- Sep 17, 20268w ago 6-K Bullish 6/10 Entry $8.67 to $8.83 Now $8.11 −6.46% ▲ +1.85% +1.24% vs SPY
- Sep 16, 20268w ago EFFECT Neutral 3/10 Entry $8.19 to $8.77 Now $8.11 −0.98% ▲ +7.08% +4.52% vs SPY
- Sep 10, 20269w ago 6-K Neutral 2/10 Entry $7.99 to $8.67 Now $8.11 +1.50% ▲ +8.51% +9.01% vs SPY
- Sep 3, 202610w ago Press Release Neutral 2/10 Entry $8.54 to $8.31 Now $8.11 −5.04% ▼ −2.69% −1.48% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers